Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution

@article{BScMed2009LongTermSI,
  title={Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution},
  author={Terence C. Chua BScMed and Tristan Dongbo Yan and Michelle E. Smigielski and Katherine J. Zhu MBBS and Keh M. Ng MBBS and Jing Zhao and David L Morris},
  journal={Annals of Surgical Oncology},
  year={2009},
  volume={16},
  pages={1903-1911}
}
Cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC) has been recognized as a treatment option for pseudomyxoma peritonei. This study reports the survival outcomes, clinicopathological prognostic factors, and a learning curve from a single institution’s experience. Patients with pseudomyxoma peritonei underwent CRS and PIC, which… CONTINUE READING